Trial Profile
Denosumab In Addition To Intense Urate-Lowering Therapy for Bone Erosions in Gout: A Pilot Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Bone disorders
- Focus Proof of concept; Therapeutic Use
- 19 Oct 2020 Status changed from recruiting to completed.
- 02 Apr 2020 Planned End Date changed from 1 Feb 2020 to 1 Mar 2021.
- 08 Aug 2019 Planned End Date changed from 1 Dec 2019 to 1 Feb 2020.